| Dr Susan D Borchers, MD | |
|
7630 Rivers Edge Dr, Columbus, OH 43235-1329 | |
| (614) 533-4000 | |
| (614) 540-3979 |
| Full Name | Dr Susan D Borchers |
|---|---|
| Gender | Female |
| Speciality | Sleep Medicine |
| Experience | 34 Years |
| Location | 7630 Rivers Edge Dr, Columbus, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386648186 | NPI | - | NPPES |
| 0157566 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 35062298 (Ohio) | Secondary |
| 207RS0012X | Internal Medicine - Sleep Medicine | 35062298 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Riverside Methodist Hospital | Columbus, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ohiohealth Corporation | 6305758426 | 1900 |
News Archive
Engineers who have induced heart cells in culture to mimic the properties of the heart have used the tissue to gain new insight into the mechanisms that spawn irregular heart rhythms.
Medical research advocates warn Congress about the dire impact that automatic spending cuts scheduled to take effect in January would have on efforts to control disease and develop life-saving treatments. Also in the news, how the concept of "fast-track" Food and Drug Administration approvals is playing on Capitol Hill.
Saturday, September 26 officially has been designated as National Day of Action, in support of National Pain Awareness Month. To help promote awareness of chronic pain and how to access help, Valley Pain Specialists, an 11-member physicians group of board-certified, fellowship-trained pain medicine specialists, are launching a speaking circuit where they plan to meet with groups of patients and physicians throughout the community to raise awareness about pain, highlight the issues surrounding pain management and address the lack of access to pain care.
For our servicewomen around the world, H.R. 3 reminds them that they must roll the dice with whatever local, non-U.S.-affiliated medical facility they can find.
An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.
› Verified 1 days ago
| Entity Name | Ohiohealth Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578545273 PECOS PAC ID: 6305758426 Enrollment ID: O20031105000532 |
News Archive
Engineers who have induced heart cells in culture to mimic the properties of the heart have used the tissue to gain new insight into the mechanisms that spawn irregular heart rhythms.
Medical research advocates warn Congress about the dire impact that automatic spending cuts scheduled to take effect in January would have on efforts to control disease and develop life-saving treatments. Also in the news, how the concept of "fast-track" Food and Drug Administration approvals is playing on Capitol Hill.
Saturday, September 26 officially has been designated as National Day of Action, in support of National Pain Awareness Month. To help promote awareness of chronic pain and how to access help, Valley Pain Specialists, an 11-member physicians group of board-certified, fellowship-trained pain medicine specialists, are launching a speaking circuit where they plan to meet with groups of patients and physicians throughout the community to raise awareness about pain, highlight the issues surrounding pain management and address the lack of access to pain care.
For our servicewomen around the world, H.R. 3 reminds them that they must roll the dice with whatever local, non-U.S.-affiliated medical facility they can find.
An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan D Borchers, MD 5450 Frantz Rd Ste 360, Dublin, OH 43016-4141 Ph: () - | Dr Susan D Borchers, MD 7630 Rivers Edge Dr, Columbus, OH 43235-1329 Ph: (614) 533-4000 |
News Archive
Engineers who have induced heart cells in culture to mimic the properties of the heart have used the tissue to gain new insight into the mechanisms that spawn irregular heart rhythms.
Medical research advocates warn Congress about the dire impact that automatic spending cuts scheduled to take effect in January would have on efforts to control disease and develop life-saving treatments. Also in the news, how the concept of "fast-track" Food and Drug Administration approvals is playing on Capitol Hill.
Saturday, September 26 officially has been designated as National Day of Action, in support of National Pain Awareness Month. To help promote awareness of chronic pain and how to access help, Valley Pain Specialists, an 11-member physicians group of board-certified, fellowship-trained pain medicine specialists, are launching a speaking circuit where they plan to meet with groups of patients and physicians throughout the community to raise awareness about pain, highlight the issues surrounding pain management and address the lack of access to pain care.
For our servicewomen around the world, H.R. 3 reminds them that they must roll the dice with whatever local, non-U.S.-affiliated medical facility they can find.
An increasing understanding of molecular pathways that regulate breast and colorectal cancer development and progression has produced new therapeutic agents, including the biologic agents trastuzumab, bevacizumab, and cetuximab. Identifying the indicators that are likely to predict which patients will achieve the best response to these agents represents a major challenge for contemporary oncologists.
› Verified 1 days ago
Sethu M. Madhavan, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 W 10th Ave, Columbus, OH 43210 Phone: 614-293-3387 Fax: 614-366-0073 | |
Amrik Singh Khalsa, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 700 Childrens Dr, Columbus, OH 43205 Phone: 614-722-2000 Fax: 614-722-4966 | |
Samuel Y. Han, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 410 W 10th Ave, Columbus, OH 43210 Phone: 614-293-6255 Fax: 614-293-1456 | |
Dr. Ruchi Bhatia, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3400 Olentangy River Rd, Columbus, OH 43202 Phone: 614-754-5500 Fax: 614-457-9519 | |
Adam T. Ramey, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 410 W 10th Ave, Columbus, OH 43210 Phone: 614-293-7499 Fax: 614-366-2360 | |
Albert J. Cook, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 460 W 10th Ave, Columbus, OH 43210 Phone: 614-293-2957 Fax: 614-685-6533 | |
Walter G. Hanel Iv, MD, PHD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 460 W 10th Ave, Columbus, OH 43210 Phone: 614-293-3196 Fax: 614-293-4812 |